Pular para o conteúdo
Alteração da proteína N-glicosilação
ORPHA:309347CID-11 · 5C54.0DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
neuro

É uma doença causada por um defeito na glicosilação N-ligada das proteínas.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A alteração da proteína N-glicosilação é uma condição genética rara em que o organismo apresenta dificuldades para montar e organizar açúcares em proteínas essenciais. Ela pode se manifestar por meio de crises epilépticas, atraso no desenvolvimento neurológico, alterações no funcionamento do fígado e traços corporais característicos. O diagnóstico pode ser estabelecido a partir de testes genéticos, existindo centenas de opções de exames cadastrados internacionalmente. A doença não consta na lista oficial de PCDT de doenças raras do Ministério da Saúde, de modo que os cuidados pelo SUS são direcionados ao alívio e controle dos sintomas presentes.

📋
Informacoes curadas por IA — podem conter imprecisoes

É uma doença causada por um defeito na glicosilação N-ligada das proteínas.

Publicações científicas
1 artigos
Último publicado: 2017 Apr
Em pesquisa
2 moléculas
EPALRESTAT, ACETAZOLAMIDE

O que está sendo pesquisado

2 moléculas em estudo — nenhuma com registro para esta doença
Ver detalhes e fases →
EPALRESTATACETAZOLAMIDE
Aparecer aqui significa que a molécula foi estudada nesta doença, não que trate. Converse com seu médico.
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
74 sintomas
🦴
Ossos e articulações
64 sintomas
😀
Face
38 sintomas
🫃
Digestivo
32 sintomas
📏
Crescimento
30 sintomas
👁️
Olhos
28 sintomas

+ 243 sintomas em outras categorias

Características mais comuns

—
Traços faciais grosseiros
—
Hepatite crônica
—
Quimiotaxia de neutrófilos prejudicada
—
Perda da camada fotorreceptora na OCT macular
—
Concentração elevada de alanina aminotransferase circulante
—
Enrugamento prematuro da pele
646sintomas
Sem dados (646)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 646 características clínicas mais associadas, ordenadas por frequência.

Traços faciais grosseirosCoarse facial features
Hepatite crônicaChronic hepatitis
Quimiotaxia de neutrófilos prejudicadaImpaired neutrophil chemotaxis
Perda da camada fotorreceptora na OCT macularPhotoreceptor layer loss on macular OCT
Concentração elevada de alanina aminotransferase circulanteElevated circulating alanine aminotransferase concentration

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa9desde 2017
Total histórico1PubMed
Últimos 10 anos1publicações
Pico20171 papers
Linha do tempo
20202017Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

24 genes identificados com associação a esta condição.

ALG3Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1D

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (1)
ALG3-congenital disorder of glycosylation
HGNC:23056UniProt:Q92685
MOGSMannosyl-oligosaccharide glucosidaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
Maturation of spike proteinMaturation of spike proteinRegulation of CDH1 posttranslational processing and trafficking to plasma membraneN-glycan trimming in the ER and Calnexin/Calreticulin cycle
MECANISMO DE DOENÇA

Type IIb congenital disorder of glycosylation

Characterized by marked generalized hypotonia and hypomotility of the neonate, dysmorphic features, including a prominent occiput, short palpebral fissures, retrognathia, high arched palate, generalized edema, and hypoplastic genitalia. Symptoms of the infant included hepatomegaly, hypoventilation, feeding problems and seizures. The clinical course was progressive and the infant did not survive more than a few months.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
86.2 TPM
Baço
83.4 TPM
Pituitária
75.9 TPM
Fibroblastos
75.1 TPM
Próstata
74.9 TPM
OUTRAS DOENÇAS (1)
MOGS-congenital disorder of glycosylation
HGNC:24862UniProt:Q13724
ALG9Alpha-1,2-mannosyltransferase ALG9Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (3)
ALG9-congenital disorder of glycosylationGillessen-Kaesbach-Nishimura syndromeautosomal dominant polycystic kidney disease
HGNC:15672UniProt:Q9H6U8
DPAGT1UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1J

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
50.3 TPM
Cervix Endocervix
43.7 TPM
Útero
39.0 TPM
Fallopian Tube
38.1 TPM
Próstata
37.8 TPM
OUTRAS DOENÇAS (3)
congenital myasthenic syndrome 13DPAGT1-congenital disorder of glycosylationobsolete congenital myasthenic syndromes with glycosylation defect
HGNC:2995UniProt:Q9H3H5
STT3BDolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3BDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
Maturation of spike proteinAsparagine N-linked glycosylationPD-L1(CD274) glycosylation and translocation to plasma membraneMaturation of DENV proteinsRegulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1X

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
168.0 TPM
Fibroblastos
124.1 TPM
Testículo
119.3 TPM
Linfócitos
112.5 TPM
Aorta
99.0 TPM
OUTRAS DOENÇAS (1)
STT3B-congenital disorder of glycosylation
HGNC:30611UniProt:Q8TCJ2
PGM1Phosphoglucomutase-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Galactose catabolismGlycogen breakdown (glycogenolysis)Glycogen synthesis
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1T

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
426.4 TPM
Coração - Ventrículo esquerdo
83.4 TPM
Aorta
80.8 TPM
Fígado
77.2 TPM
Coração - Átrio
72.0 TPM
OUTRAS DOENÇAS (1)
PGM1-congenital disorder of glycosylation
HGNC:8905UniProt:P36871
ALG11GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1P

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (1)
ALG11-congenital disorder of glycosylation
HGNC:32456UniProt:Q2TAA5
ALG2Alpha-1,3/1,6-mannosyltransferase ALG2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
OUTRAS DOENÇAS (3)
congenital myasthenic syndrome 14ALG2-congenital disorder of glycosylationobsolete congenital myasthenic syndromes with glycosylation defect
HGNC:23159UniProt:Q9H553
MGAT2Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Maturation of spike proteinReactions specific to the complex N-glycan synthesis pathway
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2A

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
35.6 TPM
Linfócitos
34.8 TPM
Testículo
21.6 TPM
Cervix Ectocervix
11.6 TPM
Baço
11.4 TPM
OUTRAS DOENÇAS (1)
MGAT2-congenital disorder of glycosylation
HGNC:7045UniProt:Q10469
MAN1B1Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Maturation of spike proteinER Quality Control Compartment (ERQC)
MECANISMO DE DOENÇA

Rafiq syndrome

An autosomal recessive disorder characterized by variably impaired intellectual and motor development, a characteristic facial dysmorphism, truncal obesity, and hypotonia. The facial dysmorphism comprises prominent eyebrows with lateral thinning, downward-slanting palpebral fissures, bulbous tip of the nose, large ears, and a thin upper lip. Behavioral problems, including overeating, verbal and physical aggression, have been reported in some cases. Serum transferrin isoelectric focusing shows a type 2 pattern.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
63.3 TPM
Nervo tibial
51.8 TPM
Pituitária
49.8 TPM
Testículo
49.4 TPM
Cérebro - Hemisfério cerebelar
47.3 TPM
OUTRAS DOENÇAS (3)
Rafiq syndromeMAN1B1-congenital disorder of glycosylationautosomal recessive non-syndromic intellectual disability
HGNC:6823UniProt:Q9UKM7
RFT1Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1N

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
20.4 TPM
Linfócitos
17.5 TPM
Nervo tibial
13.7 TPM
Ovário
12.8 TPM
Testículo
12.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
RFT1-congenital disorder of glycosylation
HGNC:30220UniProt:Q96AA3
ALG8Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1H

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (3)
polycystic liver disease 3 with or without kidney cystsALG8-congenital disorder of glycosylationautosomal dominant polycystic liver disease
HGNC:23161UniProt:Q9BVK2
SSR4Translocon-associated protein subunit deltaDisease-causing germline mutation(s) inDesconhecido
VIAS BIOLÓGICAS (1)
SRP-dependent cotranslational protein targeting to membrane
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1Y

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
176.1 TPM
Glândula salivar
121.4 TPM
Pâncreas
97.1 TPM
Baço
89.5 TPM
Cervix Endocervix
84.7 TPM
OUTRAS DOENÇAS (1)
SSR4-congenital disorder of glycosylation
HGNC:11326UniProt:P51571
SLC39A8Metal cation symporter ZIP8Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Zinc influx into cells by the SLC39 gene family
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2N

A form of congenital disorder of glycosylation, a genetically heterogeneous group of autosomal recessive, multisystem disorders caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
85.8 TPM
Glândula salivar
36.1 TPM
Linfócitos
34.2 TPM
Adipose Visceral Omentum
25.0 TPM
Cervix Endocervix
19.0 TPM
OUTRAS DOENÇAS (1)
SLC39A8-CDG
HGNC:20862UniProt:Q9C0K1
TMEM165Putative divalent cation/proton antiporter TMEM165Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2K

An autosomal recessive disorder with a variable phenotype. Affected individuals show psychomotor retardation and growth retardation, and most have short stature. Other features include dysmorphism, hypotonia, eye abnormalities, acquired microcephaly, hepatomegaly, and skeletal dysplasia. Congenital disorders of glycosylation are caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins and a wide variety of clinical features. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
62.1 TPM
Pulmão
58.4 TPM
Brain Spinal cord cervical c-1
58.3 TPM
Aorta
42.6 TPM
Vagina
40.8 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
TMEM165-congenital disorder of glycosylation
HGNC:30760UniProt:Q9HC07
STT3ADolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3ADisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (5)
Maturation of spike proteinAsparagine N-linked glycosylationPD-L1(CD274) glycosylation and translocation to plasma membraneMaturation of DENV proteinsRegulation of CDH1 posttranslational processing and trafficking to plasma membrane
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1W, autosomal recessive

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
135.1 TPM
Linfócitos
70.2 TPM
Cervix Endocervix
65.8 TPM
Ovário
62.2 TPM
Útero
59.5 TPM
OUTRAS DOENÇAS (2)
STT3A-congenital disorder of glycosylationcongenital disorder of glycosylation, type Iw, autosomal dominant
HGNC:6172UniProt:P46977
SLC35A3UDP-N-acetylglucosamine transporterDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Transport of nucleotide sugars
MECANISMO DE DOENÇA

Arthrogryposis, impaired intellectual development, and seizures

A disease characterized by arthrogryposis, intellectual disability, autism spectrum disorder, and epilepsy. Additional features include limb malformations, distal joint involvement, microcephaly, retromicrognathia, and general muscle hypotonia.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon transverso
9.7 TPM
Glândula salivar
8.7 TPM
Intestino delgado
8.6 TPM
Tireoide
7.4 TPM
Vagina
7.3 TPM
OUTRAS DOENÇAS (1)
autism spectrum disorder - epilepsy - arthrogryposis syndrome
HGNC:11023UniProt:Q9Y2D2
ALG1Chitobiosyldiphosphodolichol beta-mannosyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1K

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (1)
ALG1-congenital disorder of glycosylation
HGNC:18294UniProt:Q9BT22
ALG6Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1C

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (1)
ALG6-congenital disorder of glycosylation 1C
HGNC:23157UniProt:Q9Y672
ALG13UDP-N-acetylglucosamine transferase subunit ALG13Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent proteinDefective ALG14 causes ALG14-CMS
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 36

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. Some DEE36 patients may present with an abnormal isoelectric focusing of serum transferrin, consistent with a diagnostic classification of congenital disorder of glycosylation type I. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 36non-syndromic X-linked intellectual disability
HGNC:30881UniProt:Q9NP73
PMM2Phosphomannomutase 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Synthesis of GDP-mannose
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1A

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. CDG1A is an autosomal recessive disorder characterized by a severe encephalopathy with axial hypotonia, abnormal eye movement, and pronounced psychomotor retardation, as well as peripheral neuropathy, cerebellar hypoplasia, and retinitis pigmentosa. Patients show a peculiar distribution of subcutaneous fat, nipple retraction, and hypogonadism.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
31.1 TPM
Linfócitos
27.3 TPM
Esôfago - Mucosa
15.7 TPM
Glândula salivar
15.1 TPM
Cólon transverso
11.8 TPM
OUTRAS DOENÇAS (1)
PMM2-congenital disorder of glycosylation
HGNC:9115UniProt:O15305
ALG12Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1G

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (1)
ALG12-congenital disorder of glycosylation
HGNC:19358UniProt:Q9BV10
MPIMannose-6-phosphate isomeraseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Synthesis of GDP-mannose
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1B

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. CDG1B is clinically characterized by protein-losing enteropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
31.8 TPM
Glândula adrenal
25.9 TPM
Ovário
23.0 TPM
Fibroblastos
23.0 TPM
Testículo
21.5 TPM
OUTRAS DOENÇAS (1)
MPI-congenital disorder of glycosylation
HGNC:7216UniProt:P34949
DDOSTDolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunitDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (6)
Maturation of spike proteinAsparagine N-linked glycosylationPD-L1(CD274) glycosylation and translocation to plasma membraneMaturation of DENV proteinsRegulation of CDH1 posttranslational processing and trafficking to plasma membrane
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1R

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
426.3 TPM
Linfócitos
248.3 TPM
Ovário
225.6 TPM
Baço
223.2 TPM
Tireoide
195.4 TPM
OUTRAS DOENÇAS (1)
DDOST-congenital disorder of glycosylation
HGNC:2728UniProt:P39656

Medicamentos e terapias

EPALRESTATPhase 3

Mecanismo: Aldose reductase inhibitor

ACETAZOLAMIDEPhase 2

Mecanismo: Carbonic anhydrase XII inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

252 variantes patogênicas registradas no ClinVar.

🧬 ALG3: NM_005787.6(ALG3):c.606-2A>C ()
🧬 ALG3: NM_005787.6(ALG3):c.859C>T (p.Arg287Ter) ()
🧬 ALG3: GRCh37/hg19 3q22.1-29(chr3:132561657-197851986)x3 ()
🧬 ALG3: NM_005787.6(ALG3):c.452C>T (p.Pro151Leu) ()
🧬 ALG3: NM_005787.6(ALG3):c.1162del (p.Val388fs) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

38 vias biológicas associadas aos genes desta condição.

Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein Defective ALG3 causes CDG-1d Defective MOGS causes CDG-2b N-glycan trimming in the ER and Calnexin/Calreticulin cycle Maturation of spike protein Maturation of spike protein Regulation of CDH1 posttranslational processing and trafficking to plasma membrane Defective ALG9 causes CDG-1l Defective DPAGT1 causes CDG-1j, CMSTA2 Asparagine N-linked glycosylation Maturation of DENV proteins Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition PD-L1(CD274) glycosylation and translocation to plasma membrane Glycogen synthesis Defective PGM1 causes PGM1-CDG Neutrophil degranulation Glycogen breakdown (glycogenolysis) Galactose catabolism Defective ALG11 causes CDG-1p Defective ALG2 causes CDG-1i Defective ALG14 causes ALG14-CMS Defective MGAT2 causes CDG-2a Reactions specific to the complex N-glycan synthesis pathway Defective MAN1B1 causes MRT15 ER Quality Control Compartment (ERQC) Defective RFT1 causes CDG-1n Defective ALG8 causes CDG-1h SRP-dependent cotranslational protein targeting to membrane Zinc influx into cells by the SLC39 gene family Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) Transport of nucleotide sugars Defective ALG1 causes CDG-1k Defective ALG6 causes CDG-1c Defective PMM2 causes PMM2-CDG Synthesis of GDP-mannose Defective ALG12 causes CDG-1g Defective MPI causes MPI-CDG Advanced glycosylation endproduct receptor signaling

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 21
Medicamentos catalogadosEnsaios clínicos· 2 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Alteração da proteína N-glicosilação

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Alteração da proteína N-glicosilação.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Alteração da proteína N-glicosilação e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A doença é causada por um defeito genético no processo celular de glicosilação N-ligada das proteínas. Diversos genes estão associados a essa condição, como ALG3, MOGS, ALG9, DPAGT1, STT3B e PGM1.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

1 publicação do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:309347
    Orphanet
  2. GARD:21335
    GARD (NIH)
  3. Q55787316
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Alteração da proteína N-glicosilação. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/alteracao-da-proteina-n-glicosilacao

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Alteração da proteína N-glicosilação

ORPHA:309347 · MONDO:0017740
CID-11
Medicamentos
2 registrados
MedGen
UMLS
C5681044
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara